Showing results (1551-1560 of 2,361) with videos related to
Sort By:
Pageof 237
Clinical Neuropharmacology|September 1, 2007
The effect of duloxetine on primary pain symptoms in Parkinson diseaseRuth Djaldetti, Shlomit Yust-Katz, Vadim Kolianov, et al.Clinical Neuropharmacology|September 1, 2007
Add-on therapy with acetylcholinesterase inhibitors for memory dysfunction in schizophrenia: a systematic quantitative review, part 2Emmanuel Stip, Amir Ali Sepehry, Sylvie ChouinardClinical Neuropharmacology|October 7, 2008
Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter studyIrena Rektorova, Marek Balaz, Jindra Svatova, et al.Clinical Neuropharmacology|October 7, 2008
A case of severe parkinsonism associated with short-term treatment with milnacipranToshifumi Muraoka, Eisaku Oku, Kazuhiro Sugataka, et al.Clinical Neuropharmacology|October 7, 2008
Levetiracetam for stiff-person syndrome: report of 2 patientsW Reed Shimberg, Neha B Patel, Kelly L Sullivan, et al.Clinical Neuropharmacology|October 3, 2007
The Patient Card questionnaire to identify wearing-off in Parkinson diseasePablo Martínez-Martín, Eduardo Tolosa, Basilio Hernández, et al.Clinical Neuropharmacology|October 3, 2007
Results from a 2-year centralized tolcapone liver enzyme monitoring programMark F Lew, Greg KricorianClinical Neuropharmacology|October 3, 2007
Selegiline orally disintegrating tablets in patients with Parkinson disease and "wearing off" symptomsWilliam G Ondo, Kapil D Sethi, Greg KricorianClinical Neuropharmacology|October 3, 2007
Topiramate as treatment for hemifacial spasmHortensia Alonso-Navarro, Lluisa Rubio, Félix Javier Jiménez-JiménezClinical Neuropharmacology|October 3, 2007
Iatrogenic botulism due to therapeutic botulinum toxin a injection in a pediatric patientBeth E Crowner, Janice E Brunstrom, Brad A RacettePageof 237